Cargando…
Hepatic toxicity following actinomycin D chemotherapy in treatment of familial gestational trophoblastic neoplasia: A case report
RATIONALE: Familial hydatidiform mole is extremely rare while familial gestational trophoblastic neoplasia (GTN) has never been reported. Inspired by 2 biological sisters with postmolar GTN and liver toxicity, we reviewed susceptible maternal-effect genes and explored the role of possible drug trans...
Autores principales: | Mu, Xiyan, Yin, Rutie, Wang, Danqing, Song, Liang, Ma, Yu, Zhao, Xia, Li, Qingli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160083/ https://www.ncbi.nlm.nih.gov/pubmed/30235719 http://dx.doi.org/10.1097/MD.0000000000012424 |
Ejemplares similares
-
Effect of actinomycin D on ovarian reserve in low-risk gestational trophoblastic neoplasia
por: Xue, Wei, et al.
Publicado: (2023) -
Monotherapy for low-risk gestational trophoblastic neoplasia with score 5-6
por: Kemin, Li, et al.
Publicado: (2022) -
Actinomycin D shortage in the Brazilian market: new challenges for successful treatment of gestational trophoblastic neoplasia
por: Paulino, Eduardo, et al.
Publicado: (2019) -
Misdiagnosis of gestational trophoblastic neoplasia as ectopic pregnancy: A 15-year retrospective study
por: Xiao, Ping, et al.
Publicado: (2022) -
Outcome of treatment with EMA/EP (etoposide methotrexate and actinomycin-D/ etoposide and cisplatin) regimen in gestational trophoblastic neoplasia
por: Aminimoghaddam, Soheila, et al.
Publicado: (2018)